// App-Quantinova.ai

1575 : Time intervals between U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) new cancer therapy approvals.

Researchers

Presenter

  • Mark Lythgoe

Principal Investigators

  • Jonathan Krell

  • Jeremy Lyle Warner

  • Aakash Desai

  • Ali Raza Khaki

Medical Centers

  • Department of Oncology, Cancer Research UK Laboratories, Imperial College Healthcare NHS Trust, London, United Kingdom

  • Vanderbilt-Ingram Cancer Center, Nashville, TN

  • University of Connecticut Health Center, Farmington, CT

  • University of Washington, Seattle, WA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cancer antigen 15-3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved